Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
Nuclear Medicine and Biology|July 9, 2010
PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogueLeonie Wyffels, Giulio G Muccioli, Coco N Kapanda, et al.
Molecular Systems Biology|July 29, 2010
The endocannabinoid system links gut microbiota to adipogenesisGiulio G Muccioli, Damien Naslain, Fredrik Bäckhed, et al.
Journal of Medicinal Chemistry|April 2, 2005
Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluationGiulio G Muccioli, Diana Martin, Gerhard K E Scriba, et al.
International Journal of Pharmaceutics|March 15, 2016
Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel diseaseMelissa Guada, Ana Beloqui, Mireille Alhouayek, et al.
International Journal of Systematic and Evolutionary Microbiology|June 25, 2019
<i>Dysosmobacter welbionis</i> gen. nov., sp. nov., isolated from human faeces and emended description of the genus <i>Oscillibacter</i>Tiphaine Le Roy, Patrick Van der Smissen, Adrien Paquot, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinomaS Grottoli, V Gasco, F Broglio, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 2017
Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosaJ M Buyck, C Luyckx, G G Muccioli, et al.
Clinical and Translational Science|November 11, 2021
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical responseGabriel Stillemans, Adrien Paquot, Giulio G Muccioli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 10, 2016
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple SclerosisNicola S Orefice, Mireille Alhouayek, Antonio Carotenuto, et al.
Pageof 28